Confirmation of neurometabolic diagnoses using age‐dependent cerebrospinal fluid metabolomic profiles
Open Access
- 13 May 2020
- journal article
- research article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 43 (5), 1112-1120
- https://doi.org/10.1002/jimd.12253
Abstract
Background Timely diagnosis is essential for patients with neurometabolic disorders to enable targeted treatment. Next‐Generation Metabolic Screening allows for simultaneous screening of multiple diseases and yields a holistic view of disturbed metabolic pathways. We applied this technique to define a cerebrospinal fluid (CSF) reference metabolome and validated our approach with patients with known neurometabolic disorders. Methods Samples were measured using ultra‐high‐performance liquid chromatography‐quadrupole time‐of‐flight mass spectrometry followed by (un)targeted analysis. For the reference metabolome, CSF samples from patients with normal general chemistry results and no neurometabolic diagnosis were selected and grouped based on sex and age (0‐2/2‐5/5‐10/10‐15 years). We checked the levels of known biomarkers in CSF from 7 patients with 5 different neurometabolic disorders to confirm the suitability of our method for diagnosis. Results Untargeted analysis of 87 control CSF samples yielded 8036 features for semi‐quantitative analysis. No sex differences were found, but 1782 features (22%) were different between age groups (q < 0.05). We identified 206 diagnostic metabolites in targeted analysis. In a subset of 20 high‐intensity metabolites and 10 biomarkers, 17 (57%) were age‐dependent. For each neurometabolic patient, ≥1 specific biomarker(s) could be identified in CSF, thus confirming the diagnosis. In two cases, age‐matching was essential for correct interpretation of the metabolomic profile. Discussion In conclusion, Next‐Generation Metabolic Screening in CSF is a powerful tool in defining a diagnosis for neurometabolic disorders. Using our database with many (age‐dependent) features in CSF, our untargeted approach will facilitate biomarker discovery and further understanding of mechanisms of neurometabolic disorders.Keywords
This publication has 24 references indexed in Scilit:
- The role of reporting standards for metabolite annotation and identification in metabolomic studiesGigaScience, 2013
- Dissemination of metabolomics results: role of MetaboLights and COSMOSGigaScience, 2013
- Aromatic l-amino acid decarboxylase enzyme activity in deficient patients and heterozygotesMolecular Genetics and Metabolism, 2007
- XCMS: Processing Mass Spectrometry Data for Metabolite Profiling Using Nonlinear Peak Alignment, Matching, and IdentificationAnalytical Chemistry, 2006
- Dihydropyrimidinase Deficiency, a Progressive Neurological Disorder?Neuropediatrics, 1997
- Rostral-caudal concentration gradients of histamine metabolites in human cerebrospinal fluidInflammation Research, 1989
- Concentration gradient of CSF monoamine metabolites in children and adolescentsBiological Psychiatry, 1988
- Hypoxanthine, Xanthine, Urate and Creatinine Concentration Gradients in Cerebrospinal FluidUpsala Journal of Medical Sciences, 1988
- 5‐Hydroxytryptophol in Human Cerebrospinal Fluid: Conjugation, Concentration Gradient, Relationship to 5‐Hydroxyindoleacetic Acid, and Influence of Hereditary FactorsJournal of Neurochemistry, 1984
- Concentration Gradients of Free and Total γ‐Aminobutyric Acid and Homocarnosine in Human CSF: Comparison of Suboccipital and Lumbar SamplingJournal of Neurochemistry, 1982